A200230 Stock Overview
TELCON RF PHARMACEUTICAL. Inc. primarily engages in the development, production, and sale of RF coaxial connectors worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
TELCON RF PHARMACEUTICAL. Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩741.00 |
| 52 Week High | ₩1,280.00 |
| 52 Week Low | ₩625.00 |
| Beta | 0.078 |
| 1 Month Change | -9.96% |
| 3 Month Change | -9.08% |
| 1 Year Change | -33.48% |
| 3 Year Change | -85.78% |
| 5 Year Change | -89.85% |
| Change since IPO | -36.94% |
Recent News & Updates
Investors Shouldn't Be Too Comfortable With TELCON RF PHARMACEUTICAL's (KOSDAQ:200230) Earnings
Mar 26
TELCON RF PHARMACEUTICAL. Inc. (KOSDAQ:200230) Investors Are Less Pessimistic Than Expected
Mar 13Recent updates
Investors Shouldn't Be Too Comfortable With TELCON RF PHARMACEUTICAL's (KOSDAQ:200230) Earnings
Mar 26TELCON RF PHARMACEUTICAL. Inc. (KOSDAQ:200230) Investors Are Less Pessimistic Than Expected
Mar 13Is TELCON RF PHARMACEUTICAL (KOSDAQ:200230) Using Too Much Debt?
Apr 05Did Business Growth Power TELCON RF PHARMACEUTICAL's (KOSDAQ:200230) Share Price Gain of 218%?
Feb 03Shareholder Returns
| A200230 | KR Electronic | KR Market | |
|---|---|---|---|
| 7D | 0.1% | -3.6% | -3.3% |
| 1Y | -33.5% | -26.8% | 1.2% |
Return vs Industry: A200230 underperformed the KR Electronic industry which returned -26.8% over the past year.
Return vs Market: A200230 underperformed the KR Market which returned 1.2% over the past year.
Price Volatility
| A200230 volatility | |
|---|---|
| A200230 Average Weekly Movement | 5.9% |
| Electronic Industry Average Movement | 5.9% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 11.9% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A200230 has not had significant price volatility in the past 3 months.
Volatility Over Time: A200230's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 113 | Jin-Hun Lim | www.telcon.co.kr |
TELCON RF PHARMACEUTICAL. Inc. primarily engages in the development, production, and sale of RF coaxial connectors worldwide. It also provides coaxial couplers, distributors, and arresters, as well as cable assemblies; and pharmaceuticals.
TELCON RF PHARMACEUTICAL. Inc. Fundamentals Summary
| A200230 fundamental statistics | |
|---|---|
| Market cap | ₩82.90b |
| Earnings (TTM) | ₩13.91b |
| Revenue (TTM) | ₩36.31b |
6.0x
P/E Ratio2.3x
P/S RatioIs A200230 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A200230 income statement (TTM) | |
|---|---|
| Revenue | ₩36.31b |
| Cost of Revenue | ₩26.80b |
| Gross Profit | ₩9.51b |
| Other Expenses | -₩4.40b |
| Earnings | ₩13.91b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 124.30 |
| Gross Margin | 26.19% |
| Net Profit Margin | 38.30% |
| Debt/Equity Ratio | 25.2% |
How did A200230 perform over the long term?
See historical performance and comparison